Breaking News

You are here » Indian-Commodity  :  IPO  :  Apollo Micro Systems coming with an IPO to raise Rs 156 crore

05-Jan2018

Apollo Micro Systems coming with an IPO to raise Rs 156 crore

Apollo Micro Systems is coming out with an initial public offering (IPO) to raise about Rs 156 crore in a price band Rs 270- 275  per equity share. The issue will open on January 10, 2018 and will close on January 12, 2018. The company's shares are proposed to be listed on the BSE and NSE.

Proceeds of the fresh issue would be utilized towards meeting additional working capital and for other general corporate purposes. Aryaman Financial Services is the sole book running lead manager to the issue.

The Hyderabad-based company is in the business of designing, development and manufacturing of electronics and electro-mechanical systems including software.


Related News

View all news

Spandana Sphoorty gets SEBI's nod for IPO

Spandana Sphoorty Financial has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds through an initial public offering (IPO). The IPO consists of fresh issue......

Bharat Hotels gets SEBI's approval for IPO

Bharat Hotels has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds through an initial public offering (IPO). The IPO comprises sale of fresh equity shares......

Chartered Speed files DRHP with SEBI for public issue

Fleet bus operators Chartered Speed has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise an estimated Rs 273 crore through an Initial......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......